![Brad Rees](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brad Rees
Presidente presso G2 Therapies Pty Ltd.
Profilo
Brad Rees is currently the Chairman at G2 Therapies Pty Ltd.
He previously worked as a Managing Director at Goldman Sachs & Partners (Australia) Pty Ltd.
in 2007 and as a Director at The Garvan Institute of Medical Research.
Posizioni attive di Brad Rees
Società | Posizione | Inizio |
---|---|---|
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Presidente | - |
Precedenti posizioni note di Brad Rees
Società | Posizione | Fine |
---|---|---|
Goldman Sachs & Partners (Australia) Pty Ltd. | Presidente | 01/01/2007 |
The Garvan Institute of Medical Research
![]() The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
The Garvan Institute of Medical Research
![]() The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
Goldman Sachs & Partners (Australia) Pty Ltd. | Finance |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Health Technology |
- Borsa valori
- Insiders
- Brad Rees